Characterization of Monoclonal Antibody VN04-2 Against H5N1 Virus
Author Information
Author(s): Lim Angeline PC, Wong Steven KK, Chan Annie HY, Chan Conrad EZ, Ooi Eng Eong, Hanson Brendon J
Primary Institution: Defence Medical and Environmental Research Institute, DSO National Laboratories
Hypothesis
Can the monoclonal antibody VN04-2 provide protection against various H5N1 virus strains despite mutations?
Conclusion
The VN04-2 antibody can tolerate certain mutations in the H5N1 virus and may protect against strains from various regions.
Supporting Evidence
- VN04-2 was shown to protect mice against lethal H5N1 virus challenge.
- The antibody's binding was clade independent, indicating broad neutralizing activity.
- Three mutations in the 140s antigenic loop are required for the virus to escape antibody binding.
Takeaway
Scientists studied an antibody that helps protect against a dangerous bird flu virus, and found it can still work even if the virus changes a little.
Methodology
The study involved binding assays and neutralization tests using various H5N1 virus-like particles.
Limitations
The study's findings may not fully predict in vivo efficacy based on in vitro data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website